Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Entire DC Network
The Pricelessness Of Life Vs. Profiting From Illness: A Call For Change To The Pricing Model For Lifesaving Drugs In The United States, Aubri L. Swank
The Pricelessness Of Life Vs. Profiting From Illness: A Call For Change To The Pricing Model For Lifesaving Drugs In The United States, Aubri L. Swank
Duquesne Law Review
Pharmaceutical drug prices in the United States are at the highest costs yet seen, and it looks like these prices are still continuing to climb. While people in the United States are struggling to pay for necessary medications, the prices of those same medications are drastically lower in other countries.
This Article directly analyzes the issue of pharmaceutical pricing in the United States through two specific lifesaving drugs, insulin and epinephrine. Both drugs are prescriptions required to keep some people alive, and both are related to manufacturing companies with questionable, overwhelming control of the markets. While there has been recent …